Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Clicks: 161
ID: 270987
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
161 views
27 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #388 of 1,084 articles by views in clinical infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
AbstractBackground. Antimicrobial-resistant infections are commonly encountered in US hospitals and result in significant morbidity and mortality. This guidance
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (18 words).
Try re-searching for a better abstract.
| Reference Key |
d2021clinicalinfectious
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tamma, Pranita D;Aitken, Samuel L;Bonomo, Robert A;Mathers, Amy J;van Duin, David;Clancy, Cornelius J; |
| Journal | clinical infectious diseases |
| Year | 2021 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.